Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (151-160 of 292) with videos related to

Pageof 30
Sort By:
Human Pathology|December 28, 2016
βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancerAndrea Hinsch, Aref Chaker, Christian Burdelski, et al.
BJU International|September 24, 2017
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma CollaborationAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
World Journal of Urology|April 19, 2020
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinomaTill Eichenauer, Luca Simmendinger, Christoph Fraune, et al.
Anticancer Research|April 30, 2014
MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotypeStefan Steurer, Ahmad Shoaib Seddiqi, Julius Magnus Singer, et al.
Urologic Oncology|May 27, 2014
Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomyAtiqullah Aziz, Hans-Martin Fritsche, Georgios Gakis, et al.
Urologic Oncology|September 5, 2012
Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomyMichael Rink, Kyung Park, Björn G Volkmer, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly -An International Multicenter StudyVictor M Schuettfort, Benjamin Pradere, Hadi Mostafaei, et al.
World Journal of Urology|May 4, 2020
A non-diploid DNA status is linked to poor prognosis in renal cell cancerFranziska Büscheck, Christoph Fraune, Martina Kluth, et al.
World Journal of Urology|September 9, 2016
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)Francesco Soria, Shahrokh F Shariat, Seth P Lerner, et al.
Acta Oncologica (Stockholm, Sweden)|November 5, 2021
Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR studyManuela Schmidinger, Robert J Motzer, Frederic Rolland, et al.
Pageof 30

Showing results (151-160 of 292) with videos related to

Sort By:
Pageof 30
Human Pathology|December 28, 2016
βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancerAndrea Hinsch, Aref Chaker, Christian Burdelski, et al.
BJU International|September 24, 2017
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma CollaborationAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
World Journal of Urology|April 19, 2020
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinomaTill Eichenauer, Luca Simmendinger, Christoph Fraune, et al.
Anticancer Research|April 30, 2014
MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotypeStefan Steurer, Ahmad Shoaib Seddiqi, Julius Magnus Singer, et al.
Urologic Oncology|May 27, 2014
Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomyAtiqullah Aziz, Hans-Martin Fritsche, Georgios Gakis, et al.
Urologic Oncology|September 5, 2012
Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomyMichael Rink, Kyung Park, Björn G Volkmer, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly -An International Multicenter StudyVictor M Schuettfort, Benjamin Pradere, Hadi Mostafaei, et al.
World Journal of Urology|May 4, 2020
A non-diploid DNA status is linked to poor prognosis in renal cell cancerFranziska Büscheck, Christoph Fraune, Martina Kluth, et al.
World Journal of Urology|September 9, 2016
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)Francesco Soria, Shahrokh F Shariat, Seth P Lerner, et al.
Acta Oncologica (Stockholm, Sweden)|November 5, 2021
Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR studyManuela Schmidinger, Robert J Motzer, Frederic Rolland, et al.
Pageof 30